These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22635230)

  • 1. Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome.
    De Carolis S; Botta A; Santucci S; Salvi S; Moresi S; Di Pasquo E; Del Sordo G; Martino C
    Lupus; 2012 Jun; 21(7):776-8. PubMed ID: 22635230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?
    Reggia R; Ziglioli T; Andreoli L; Bellisai F; Iuliano A; Gerosa M; Ramoni V; Tani C; Brucato A; Galeazzi M; Mosca M; Caporali R; Meroni PL; Tincani A
    Rheumatology (Oxford); 2012 Dec; 51(12):2186-90. PubMed ID: 22923750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
    Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of 139 pregnancies in antiphospholipid-positive women not fulfilling criteria for antiphospholipid syndrome: a retrospective study.
    Del Ross T; Ruffatti A; Visentin MS; Tonello M; Calligaro A; Favaro M; Hoxha A; Punzi L
    J Rheumatol; 2013 Apr; 40(4):425-9. PubMed ID: 23418380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
    Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.
    Lackman F; Capewell V; Richardson B; daSilva O; Gagnon R
    Am J Obstet Gynecol; 2001 Apr; 184(5):946-53. PubMed ID: 11303203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of 75 pregnancies in patients with antiphospholipid syndrome.
    Huong DL; Wechsler B; Bletry O; Vauthier-Brouzes D; Lefebvre G; Piette JC
    J Rheumatol; 2001 Sep; 28(9):2025-30. PubMed ID: 11550970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory and clinical features of pregnant women with antiphospholipid syndrome and neonatal outcome.
    Ruffatti A; Calligaro A; Hoxha A; Trevisanuto D; Ruffatti AT; Gervasi MT; Cuffaro S; Pengo V; Punzi L
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):302-7. PubMed ID: 20391475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
    Cohen D; Buurma A; Goemaere NN; Girardi G; le Cessie S; Scherjon S; Bloemenkamp KW; de Heer E; Bruijn JA; Bajema IM
    J Pathol; 2011 Dec; 225(4):502-11. PubMed ID: 21688269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus.
    Clowse ME; Magder LS; Petri M
    J Rheumatol; 2011 Jun; 38(6):1012-6. PubMed ID: 21406496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementemia in pregnancies with antiphospholipid syndrome.
    Tabacco S; Giannini A; Garufi C; Botta A; Salvi S; Del Sordo G; Benedetti Panici P; Lanzone A; De Carolis S
    Lupus; 2019 Nov; 28(13):1503-1509. PubMed ID: 31623520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes in patients with systemic autoimmunity.
    Canti V; Castiglioni MT; Rosa S; Franchini S; Sabbadini MG; Manfredi AA; Rovere-Querini P
    Autoimmunity; 2012 Mar; 45(2):169-75. PubMed ID: 21875380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
    Vega J; Sáez G; Smith M; Agurto M; Morris NM
    Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between TORCH complex false positivity and obstetric outcome in patients with antiphospholipid syndrome.
    De Carolis S; Santucci S; Botta A; Salvi S; Degennaro VA; Garufi C; Garofalo S; Ferrazzani S; Scambia G
    Lupus; 2012 Jun; 21(7):773-5. PubMed ID: 22635229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
    Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome: An update on risk factors for pregnancy outcome.
    De Carolis S; Tabacco S; Rizzo F; Giannini A; Botta A; Salvi S; Garufi C; Benedetti Panici P; Lanzone A
    Autoimmun Rev; 2018 Oct; 17(10):956-966. PubMed ID: 30118899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnancy and antiphospholipid antibodies in systemic lupus erithematosus patients: an outcome evaluation].
    Cordeiro A; Lermann R; Ambrósio P; Nogueira I; Serrano F
    Acta Reumatol Port; 2009; 34(3):486-91. PubMed ID: 19820672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy.
    Ruffatti A; Tonello M; Cavazzana A; Bagatella P; Pengo V
    Thromb Res; 2009; 123(3):482-7. PubMed ID: 18462781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary antiphospholipid syndrome: pregnancy outcome in a portuguese population.
    Serrano F; Nogueira I; Borges A; Branco J
    Acta Reumatol Port; 2009; 34(3):492-7. PubMed ID: 19820673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.